However, there was no significantly different incidence of CBNM between HPV-positive and HPV-negative patients
Experts Discuss HPV-Positive Head and Neck Cancer
De-intensifying both surgical and radiation treatment can be effective in some patients
New Staging System Proposed for HPV-Related Oropharyngeal Cancer
Researchers propose a new staging system for human papillomavirus-related oropharyngeal cancers based on findings from the International Collaboration on Oropharyngeal cancer Network for Staging (ICON-S) study.
Optimizing Treatment for Oropharyngeal Cancer
The possibility of de-escalating treatment is being evaluated in a clinical trial of participants with HPV-positive stage III-IVA oropharyngeal cancer
Risk of Oral HPV Infections and OSCC Linked to Cumulative Exposure to Oral Sexual Activity
Emerging evidence shows that the demographic profile of groups at risk of oral HPV infections and OSCC is linked to cumulative exposure to oral sexual activity
Oral Rinse Samples of HPV DNA May Identify Recurrence Risk
For patients diagnosed with human papillomavirus (HPV)-related oropharyngeal cancer, detection of HPV DNA in oral rinse samples after diagnosis may provide a useful biomarker to identify patients at increased risk of recurrence after treatment
Adult-Onset Recurrent Respiratory Papillomatosis May Be Associated with Number of Sexual Partners
What risk factors, if any, are strongly associated with adult-onset recurrent respiratory papillomatosis (AO-RRP)?
COSM14: HPV Status and Prognosis for Oropharyngeal Cancers
Experts share insights on HPV risk factors, effectiveness of vaccinations, treatment
Does Exposure to Laser Plume Place the Surgeon at High Risk for Acquiring Clinical HPV Infection?
Risk of transmission of HPV to surgeons appears to be low, and evacuation of plume from surgical field is an effective strategy to prevent viral contamination
Further Research Needed for HPV-Related Cancer Surveillance
Otolaryngologists say more information is needed to assess utility of post-treatment PET/CT scans for patients with HPV-related cancer